Pages Menu
Categories Menu

Posted by on Apr 9, 2008 in FDA, Pharma, Toxicology

FDA Updates Likely Heparin Death Toll

FDA Updates Likely Heparin Death Toll

The FDA has released new information on the number of reported heparin-related deaths and the subset of deaths associated with allergic or hypotensive symptoms since January 2007. According to the FDA, there have been 103 reported deaths since the beginning of 2007, 91 (88%) of which were reported during 2008. Among these deaths, 62 (60%) were associated with one or more allergic or hypotensive reactionsthe kinds of reactions that led to the recent recall of Baxter’s heparin; 56 of the 62 were reported during 2008. The FDA advises that the presence of allergic or hypotensive symptoms does not necessarily indicate a cause of death.


FDA_heparin_deaths2.jpgAlso according to FDA records, there were 55 heparin-associated deaths during 2006 in individuals with “a variety of underlying medical conditions.” Only 3 were reported to be associated with allergic or hypotensive events.

*Heparin from any manufacturer.

bmartin (1127 Posts)

A native East Tennessean, Barbara Martin is a formerly practicing, board-certified neurologist who received her BS (psychology, summa cum laude) and MD from Duke University before completing her postgraduate training (internship, residency, fellowship) at the Hospital of the University of Pennsylvania in Philadelphia. She has worked in academia, private practice, medical publishing, drug market research, and continuing medical education (CME). For the last 3 years, she has worked in a freelance capacity as a medical writer, analyst, and consultant. Follow Dr. Barbara Martin on and Twitter.